Page last updated: 2024-09-04

cpi 1189 and Movement Disorders

cpi 1189 has been researched along with Movement Disorders in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Clifford, DB; Cohen, BA; Ellis, RJ; Kieburtz, K; Letendre, S; Marder, K; Marra, CM; McArthur, JC; McDermott, MP; Schifitto, G	1

Trials

1 trial(s) available for cpi 1189 and Movement Disorders

Article	Year
A randomized clinical trial of CPI-1189 for HIV-associated cognitive-motor impairment. Neurology, 2002, Nov-26, Volume: 59, Issue:10 Topics: Adult; AIDS Dementia Complex; Antioxidants; Biomarkers; Butanes; Cognition Disorders; Double-Blind Method; Female; Humans; Male; Movement Disorders; Neurologic Examination; Neuropsychological Tests; Nitrogen Oxides; Patient Compliance; Psychometrics; Treatment Outcome; Tumor Necrosis Factor-alpha	2002

Article

Year

A randomized clinical trial of CPI-1189 for HIV-associated cognitive-motor impairment.

Neurology, 2002, Nov-26, Volume: 59, Issue:10

Topics: Adult; AIDS Dementia Complex; Antioxidants; Biomarkers; Butanes; Cognition Disorders; Double-Blind Method; Female; Humans; Male; Movement Disorders; Neurologic Examination; Neuropsychological Tests; Nitrogen Oxides; Patient Compliance; Psychometrics; Treatment Outcome; Tumor Necrosis Factor-alpha

2002